Abstract. Epithelial-mesenchymal transition (EMT) is associated with tumor malignancy. The hedgehog-EMT pathway is preferentially activated in diffuse-type gastric cancer (GC) compared with intestinal-type GC; however, histological typing is currently the only method for distinguishing these two major types of GC. We compared the gene expression profiles of 12 bone marrow-derived mesenchymal stem cell cultures and 5 diffuse-type GC tissue samples. Numerous upregulated or downregulated genes were identified in diffuse-type GC, including CDH1, CDH2, VIM, WNT4 and WNT5. Among these genes, the mRNA ratio of CDH2 to CDH1 could distinguish the 15 diffuse-type GC samples from the 17 intestinal-type GC samples. Our results suggested that the mesenchymal features were more prominent in diffuse-type GC than in intestinal-type GC, but were weaker in diffuse-type GC than in mesenchymal stem cells. Diffuse-type GC that has undergone extensive EMT, which has a poor prognosis, can be identified by quantitative PCR analysis of only two genes.
Introduction
Gene expression is dramatically deregulated in tumor development and progression. Various epithelial cell-derived cancers often have mesenchymal features. Epithelial-mesenchymal transition (EMT) is a physiological phenotypic shift in which epithelial cells with cell-cell and cell-extracellular matrix connections transform into mesenchymal cells and then migrate to other locations within the body (1) . EMT is a key developmental process that is often activated during cancer invasion and metastasis, and EMT in immortalized human mammary epithelial cells results in the development of mesenchymal cells and the expression of stem-cell markers (2) . These insights highlight the need to investigate the relationship between cancer and mesenchymal cells. Cancer genomic landscapes have been revealed, and mutations in cancer-associated genes involved in cell proliferation have been discovered (3) . Here, we report that the expression of several genes involved in EMT or stem cell development is altered in cancer cells and mesenchymal stem cells (MSCs).
Gastric cancer (GC) is one of the leading causes of cancer-related deaths worldwide. Histopathologically, GC can be divided into two major categories: intestinal-type and diffuse-type. Intestinal-type GC develops via sequential stages including Helicobacter pylori (H. pylori)-associated gastritis, intestinal metaplasia (IM) and dysplasia. This type is found predominantly in high-risk geographic areas, such as East Asia, and is strongly correlated with the prevalence of H. pylori infection among the elderly. In contrast, diffuse-type GC appears in half of all GC cases and is more geographically dispersed. Diffuse-type GC typically develops from H. pylori-free, morphologically normal gastric mucosa without atrophic gastritis, or IM, and is both genetically and phenotypically different from intestinal-type GC (4) (5) (6) (7) (8) . Unlike the decreasing incidence of intestinal-type GC, the prevalence of diffuse-type GC is reportedly increasing worldwide. Therefore, the molecular characterization of diffuse-type GC, with a particular focus on its infiltrating and scattered growth, is important for the development of novel therapeutics for this disease. The infiltrating and scattered growth of diffuse-type GC has been reported to be mediated by the loss of E-cadherin [cadherin 1, type 1, E-cadherin (epithelial) (CDH1)] function through somatic mutation, promoter methylation and cancer-associated downregulation (9) . We previously reported that the activation of hedgehog (Hh) signaling selectively occurs in diffuse-type GC and that blocking the Hh signal inhibits the growth of GC cells in which Hh has been activated (6) . We also reported that the EMT regulator ZEB1/SIP1 is a target of Hh signaling in diffuse-type GC and that ZEB1 regulates mesenchymal-related genes WNT5A, CDH2 [ 
Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition
MEF2C that are preferentially expressed in diffuse-type GC (7) . Thus, the hedgehog-EMT pathway is preferentially activated in diffuse-type GC compared with intestinal-type GC; however, histological typing is currently the only method to distinguish the two major types. Here, we report that diffusetype GC that has undergone extensive EMT, which has a poor prognosis, was distinguished from intestinal-type GC by quantitative real-time RT-PCR analysis of only two genes.
Materials and methods
Cell culture. Human MSCs from bone marrow (Lonza, Walkersville, MD, USA) were cultured in mesenchymal stem cell growth medium (MSCGM; Lonza #PT-3001; MSC basal medium supplemented with mesenchymal cell growth supplement, L-glutamine, and penicillin/streptomycin) at 37˚C in a 5% CO 2 incubator. The cells were passaged according to the manufacturer's protocol, with a slight modification in the use of trypsin-EDTA solution (Lonza #CC-3232). The following lot numbers of human MSC batches were utilized: #4F1127, #4F0312, #5F0138, #4F1560, #4F0591 and #4F0760. Informed consent was obtained for the development of the Poietics human mesenchymal stem cell systems (Lonza) (10) .
Total RNA purification and extraction. The MSCs were cultured on a 10-cm dish, lysed in 600 µl of buffer RLT (RNeasy lysis buffer) with β-mercaptoethanol, and homogenized using a QIA shredder (Qiagen, Düsseldorf, Germany). Total RNA was purified using RNeasy mini spin columns according to the manufacturer's protocol (Qiagen). Total RNA was eluted with RNase-free water (10) . Cancer samples were lysed with Isogen lysis buffer and total RNA was extracted by precipitation with isopropanol (11) .
Microarray analysis. Total RNA (100 ng) was reverse transcribed and amplified using a GeneChip kit (Affymetrix, Santa Clara, CA, USA). The microarray analysis was performed using GeneChip Human Genome U95Av2 or U133 Plus2.0 (Affymetrix) in accordance with the manufacturer's instructions (10, 11) . Human bone marrow-derived MSCs are commercially available from Lonza, and gastric cancer cells were obtained from the National Cancer Center Research Institute. The microarray data on human MSCs and gastric cancer are available to the public in NCBI's Gene Expression Omnibus (GEO) database and are accessible via GEO Series accession number GSE7888 and GSE42252, respectively (10, 12) .
Quantitative real-time RT-PCR analysis.
Real-time RT-PCR was performed using primer sets designed for detecting CDH1 (5'-GGGGTAGTGAGGATCTTGAT-3' and 5'-TCCTTTTCC ACCCCCAAAGA-3'), CDH2 (5'-GGCATAGTCTATGGA GAAGT-3' and 5'-GCTGTTGTCAGAAGTCTCTC-3') and VIM (5'-GCTTTCAAGTGCCTTTCTGC-3' and 5'-GTT GGTTGGATACTTGCTGG-3'). Quantitative real-time PCR was performed using a Bio-Rad iCycler with iQ SYBR-Green Super mix as previously reported (11). The relative mRNA expression level of each gene was normalized to that of ACTB (β-actin: 5'-GAAGTCCCTTGCCATCCTAA-3' and 5'-GCA CGAAGGCTCATCATTCA-3') using the ∆∆Ct method.
Statistics. Student's t-test or Wilcoxon's U test was performed to calculate the P-values. Microsoft Excel and GeneSpring software (Agilent Technologies, Ltd., CA, USA) were used for the analyses.
Results

Comparing the expression of EMT-related genes in MSCs and diffuse-type GC.
The microarray gene expression analysis identified 51 upregulated probe sets that had detectable cells in either all of the 12 MSC samples or all of the 5 diffuse-type GC samples; the average GAPDH-normalized signal intensity of these upregulated probe sets in MSCs was >10-fold higher than the average GAPDH-normalized signal intensity in diffuse-type GC (P<0.0001) (Tables I and  II) . This class of probe sets contained probes recognizing CDH2, which encodes N-cadherin, a protein that has been reported to be involved in EMT (13) . CDH2 was upregulated in 12 MSC samples compared with the 5 diffuse-type GC samples (Fig. 1A) . A previous report demonstrated that CDH2 is a marker of EMT (13) . E-cadherin stabilizes cellular organization or conformation (14) . The expression of CDH1 (E-cadherin), which plays an important role in the cell junctions of epithelial cells, was downregulated in MSCs compared with diffuse-type GC (Fig. 1B) . It has been reported that HMLER cancer cells (human mammary epithelial cells transformed with genomic versions of SV40 large-T, hTERT and H-rasV12) have an increased CD44 high /CD24 low cancer stem cell (CSC) fraction after treatment with small interfering RNA targeting CDH1 (15, 16) . This report details the involvement of CDH1 in interfering with the CSC phenotype and in inducing stem cell differentiation. Considering the expression patterns of CDH2 and CDH1 in MSCs and diffuse-type GC, most of the cells in diffuse-type GC are likely to have an epithelial-like phenotype, although there is more evidence of EMT in diffuse-type GC than in intestinal-type GC.
We further examined mesenchymal phenotype-related genes in 5 diffuse-type GC samples and identified 1461 upregul ated probe sets with an average signal intensity >500 in the 12 MSC samples and with greater than a 2-fold change in the 12 MSC samples compared with the 5 diffuse-type GC samples using the U133Plus2.0 platform. Of these 1461 probe sets, 983 were aligned with the U95Av2 platform. Using the U95Av2 platform, 94 probe sets were determined to be upregulated in the 13 diffuse-type GC samples compared with the 17 intestinaltype GC samples (Fig. 2) . Probe sets that recognized the same symbol were unified in probe sets with a larger fold-change and 77 genes were selected (Table III) . FN1 ( fibronectin 1) was upregulated in MSCs compared with diffuse-type GC (Fig. 3A) . It has been reported that salinomycin has selective toxicity in the stem cells of epithelial cell-derived cancers and that it induces epithelial cell differentiation (17) . Salinomycin, a selective breast cancer stem cell inhibitor, has been reported to decrease stem cell-related genes such as CCND1 (cyclin D1), LEF1 and FN1, which are targets of Wnt signaling (17) . The role of Wnt signaling in different cell types may be an interesting target for cancer stem cell machinery (18, 19) . Gene expression was analyzed to investigate whether these stem cell-related genes were involved in the cellular phenotypic changes. FN1 was upregulated in MSCs compared with diffuse-type GC, suggesting that the stem cell phenotype was more typical in MSCs than in diffuse-type GC (Fig. 3A) . One of the probe sets recognizing VIM (vimentin) was upregulated in diffuse-type GC compared with MSCs (Fig. 3B ).
Comparing the expression of stem cell-related genes in MSCs and diffuse-type GC. To identify markers of EMT or the stemness phenotype of diffuse-type GC, we compared the expression of stem cell-related genes in MSCs and diffusetype GC. We first selected stem-cell related genes based on biological processes using gene ontology and then performed a clustering analysis of the signal intensity of 33 stem cell-related genes that had greater than a 5-fold change in the GAPDHnormalized signal intensity in GC compared with MSCs (NCSS2007) (Fig. 4A ). Among these 33 stem cell-related genes, 10 were selected that were significantly differentially expressed (more than a 20-fold change; P<0.01 and P<0.05; n=12 MSCs and n=5 diffuse-type GCs) (Fig. 4B) . SOX2, which is involved in embryonic and adult tissue stem cell maintenance, was upregulated in diffuse-type GC compared with MSCs. This corresponded with previous reports indicating that SOX2 was overexpressed or mutated in a stage-dependent response, mitochondrial electron transport, NADH to ubiquinone, nervous system development, negative regulation of neuroblast proliferation, axon guidance, axon target recognition, behavior, learning or memory, feeding behavior, neuron recognition, response to hormone stimulus, glutamate secretion, response to fluoxetine, dendrite development, regulation of metabolic process, nerve development, response to nutrient levels, response to vitamin A, mechanoreceptor differentiation, response to drug, fear response, negative regulation of apoptotic process, regulation of neuron apoptotic process, negative regulation of neuron apoptotic process, positive regulation of neuron differentiation, negative regulation of striated muscle tissue development, regulation of retinal cell programmed cell death, regulation of synaptic plasticity, regulation of long-term neuronal synaptic plasticity, positive regulation of long-term neuronal synaptic plasticity, regulation of short-term neuronal synaptic plasticity, inner ear development, cognition, positive regulation of synapse assembly, response to hyperoxia, regulation of excitatory postsynaptic membrane potential, response to anesthetic 1552487_a_at BNC1
Transcription, DNA-dependent, regulation of transcription, DNA-dependent, regulation of transcription from RNA polymerase I promoter, regulation of transcription from RNA polymerase II promoter, positive regulation of cell proliferation, epidermis development, wound healing, positive regulation of epithelial cell proliferation, chromosome organization 236532_at C11orf87  -1557180_at  1557181_s_at  229641_at CCBE1 Angiogenesis, lymphangiogenesis, sprouting angiogenesis, multicellular organismal development, venous blood vessel morphogenesis 203440_at CDH2 Cell adhesion, homophilic cell adhesion, heterophilic cell-cell adhesion, synapse assembly, cellcell adhesion, calcium-dependent cell-cell adhesion, cell migration, regulation of myelination, regulation of protein localization, cell junction assembly, adherens junction organization, regulation of Rho protein signal transduction, muscle cell differentiation, positive regulation of MAPK cascade, cell-cell junction organization, blood vessel morphogenesis, regulation of axonogenesis, striated muscle cell differentiation, positive regulation of muscle cell differentiation, negative regulation of canonical Wnt receptor signaling pathway 204602_at DKK1 Negative regulation of transcription from RNA polymerase II promoter, cell morphogenesis involved in differentiation, endoderm formation, mesoderm formation, hair follicle development, regulation of receptor internalization, multicellular organismal development, endoderm development, Wnt receptor signaling pathway, regulation of Wnt receptor signaling pathway, negative regulation of Wnt receptor signaling pathway, embryonic limb morphogenesis, negative regulation of BMP signaling pathway, forebrain development, negative regulation of protein complex assembly, response to retinoic acid, negative regulation of peptidyl-serine phosphorylation, negative regulation of mesodermal cell fate specification, regulation of endodermal cell fate specification, negative Angiogenesis, platelet degranulation, acute-phase response, cell-substrate junction assembly, cell 214702_at adhesion, cell-matrix adhesion, calcium-independent cell-matrix adhesion, blood coagulation, regulation of cell shape, response to wounding, positive regulation of peptidase activity, cell migration, peptide cross-linking, platelet activation, extracellular matrix organization, substrate adhesion-dependent cell spreading, wound healing, leukocyte migration 206307_s_at FOXD1
Neural crest cell migration, transcription, DNA-dependent, regulation of transcription, DNAdependent, pattern specification process, peripheral nervous system development, embryo development, positive regulation of gene expression, melanocyte differentiation, positive regulation of BMP signaling pathway, negative regulation of transcription, DNA-dependent, positive regulation of transcription from RNA polymerase II promoter, enteric nervous system development, sympathetic nervous system development, axon extension involved in axon guidance, lateral line nerve glial cell development, iridophore differentiation, regulation of sequence-specific DNA binding transcription factor activity, cartilage development, dichotomous subdivision of terminal units involved in ureteric bud branching, metanephric capsule development, metanephric capsule specification, positive regulation of kidney development 204948_s_at FST Negative regulation of transcription from RNA polymerase II promoter, hematopoietic progenitor 207345_at cell differentiation, gamete generation, pattern specification process, female gonad development, 226847_at BMP signaling pathway, hair follicle morphogenesis, negative regulation of activin receptor signaling pathway, odontogenesis of dentin-containing tooth, keratinocyte proliferation, negative regulation of cell differentiation, negative regulation of follicle-stimulating hormone secretion, positive regulation of hair follicle development 209905_at HOXA10-Transcription, DNA-dependent, regulation of transcription, DNA-dependent, multicellular HOXA9, organismal development, anterior/posterior pattern specification, proximal/distal pattern formation, HOXA9, mammary gland development, embryonic forelimb morphogenesis, endothelial cell activation, MIR196B negative regulation of myeloid cell differentiation, embryonic skeletal system development, definitive hemopoiesis 203851_at IGFBP6 Regulation of cell growth, signal transduction, negative regulation of cell proliferation, cellular protein metabolic process 210261_at KCNK2 Transport, ion transport, potassium ion transport, G-protein coupled receptor signaling pathway, synaptic transmission, regulation of ion transmembrane transport, potassium ion transmembrane transport 244623_at KCNQ5 Protein complex assembly, transport, ion transport, potassium ion transport, synaptic transmission, regulation of ion transmembrane transport, transmembrane transport, potassium ion transmembrane transport 233533_at KRTAP1-5 -243813_at LINC00968 -204298_s_at LOX Blood vessel development, cellular protein modification process, response to hormone stimulus, 213640_s_at extracellular matrix organization, collagen fibril organization, lung development, wound healing, 215446_s_at response to drug, elastic fiber assembly, response to steroid hormone stimulus, oxidation-reduction process Negative regulation of transcription from RNA polymerase II promoter, patterning of blood vessels, vasculogenesis, in utero embryonic development, neuron migration, extraocular skeletal muscle development, atrioventricular valve development, cardiac neural crest cell migration involved in outflow tract morphogenesis, pulmonary myocardium development, regulation of transcription, DNA-dependent, regulation of transcription from RNA polymerase II promoter, transcription from RNA polymerase II promoter, multicellular organismal development, determination of left/right symmetry, brain development, heart development, skeletal muscle tissue development, myoblast fusion, male gonad development, female gonad development, anatomical structure morphogenesis, response to hormone stimulus, organ morphogenesis, Wnt receptor signaling pathway, subthalamic nucleus development, hypothalamus cell migration, pituitary gland development, neuron differentiation, lung development, regulation of cell migration, embryonic cameratype eye development, response to vitamin A, embryonic hindlimb morphogenesis, hair cell differentiation, vascular smooth muscle cell differentiation, deltoid tuberosity development, regulation of cell proliferation, odontogenesis of dentin-containing tooth, odontogenesis, cameratype eye development, positive regulation of DNA binding, positive regulation of transcription, DNA-dependent, positive regulation of transcription from RNA polymerase II promoter, spleen development, embryonic digestive tract morphogenesis, cardiac muscle tissue development, cardiac muscle cell differentiation, atrial cardiac muscle tissue morphogenesis, ventricular cardiac muscle cell development, digestive system development, somatotropin secreting cell differentiation, prolactin secreting cell differentiation, ventricular septum morphogenesis, left lung morphogenesis, pulmonary vein morphogenesis, superior vena cava morphogenesis, endodermal digestive tract morphogenesis, iris morphogenesis, cell proliferation involved in outflow tract morphogenesis, left/right axis specification, positive regulation of myoblast proliferation 219729_at PRRX2 Positive regulation of mesenchymal cell proliferation, regulation of transcription, DNA-dependent, multicellular organismal development, embryonic limb morphogenesis, inner ear morphogenesis, middle ear morphogenesis, positive regulation of smoothened signaling pathway, embryonic cranial skeleton morphogenesis, embryonic skeletal system morphogenesis, artery morphogenesis, cartilage development 210367_s_at PTGES Prostaglandin biosynthetic process, acute inflammatory response, chronic inflammatory response, lipid metabolic process, fatty acid metabolic process, fatty acid biosynthetic process, prostaglandin metabolic process, signal transduction, negative regulation of cell proliferation, response to organic cyclic compound, arachidonic acid metabolic process, cyclooxygenase pathway, response to lipopolysaccharide, response to retinoic acid, response to cytokine stimulus, small molecule metabolic process, response to calcium ion 206157_at PTX3 Response to yeast, inflammatory response, opsonization, positive regulation of nitric oxide biosynthetic process, positive regulation of phagocytosis 239202_at RAB3B GTP catabolic process, transport, intracellular protein transport, nucleocytoplasmic transport, signal transduction, small GTPase mediated signal transduction, protein transport, regulation of exocytosis, peptidyl-cysteine methylation 235417_at SPOCD1 Transcription, DNA-dependent, negative regulation of phosphatase activity 203438_at STC2 Cellular calcium ion homeostasis, response to oxidative stress, cell surface receptor signaling Probe set ID Gene symbol Gene ontology biological process 203439_s_at pathway, cell-cell signaling, embryo implantation, response to nutrient, endoplasmic reticulum unfolded protein response, response to vitamin D, response to endoplasmic reticulum stress, negative regulation of multicellular organism growth, response to peptide hormone stimulus, decidualization, calcium ion homeostasis, cellular response to hypoxia, regulation of store-operated calcium entry 201107_s_at THBS1 Activation of MAPK activity, response to hypoxia, negative regulation of endothelial cell proliferation, negative regulation of cell-matrix adhesion, sprouting angiogenesis, chronic inflammatory response, platelet degranulation, negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II, negative regulation of dendritic cell antigen processing and presentation, outflow tract morphogenesis, endocardial cushion development, growth plate cartilage development, induction of apoptosis, inflammatory response, immune response, cell cycle arrest, cell adhesion, blood coagulation, response to glucose stimulus, positive regulation of endothelial cell migration, negative regulation of endothelial cell migration, negative regulation of plasma membrane long-chain fatty acid transport, negative regulation of nitric oxide mediated signal transduction, negative regulation of cGMP-mediated signaling, negative regulation of plasminogen activation, positive regulation of macrophage chemotaxis, positive regulation of fibroblast migration, positive regulation of cell-substrate adhesion, cell migration, negative regulation of angiogenesis, peptide cross-linking, platelet activation, positive regulation of blood coagulation, extracellular matrix organization, positive regulation of cell migration, positive regulation of transforming growth factor beta receptor signaling pathway, response to magnesium ion, response to progesterone stimulus, negative regulation of interleukin-12 production, positive regulation of transforming growth factor beta1 production, cellular response to heat, response to endoplasmic reticulum stress, negative regulation of fibroblast growth factor receptor signaling pathway, positive regulation of phosphorylation, response to drug, positive regulation of tumor necrosis factor biosynthetic process, positive regulation of macrophage activation, negative regulation of apoptotic process, negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, positive regulation of blood vessel endothelial cell migration, negative regulation of blood vessel endothelial cell migration, engulfment of apoptotic cell, positive regulation of translation, positive regulation of angiogenesis, behavioral response to pain, blood vessel morphogenesis, positive regulation of chemotaxis, response to calcium ion, negative regulation of focal adhesion assembly, positive regulation of protein kinase B signaling cascade, negative regulation of fibrinolysis, positive regulation of execution phase of apoptosis, positive regulation of extrinsic apoptotic signaling pathway via death domain receptors, positive regulation of endothelial cell apoptotic process, positive regulation of reactive oxygen species metabolic process, negative regulation of extrinsic apoptotic signaling pathway 201387_s_at UCHL1 Proteolysis, ubiquitin-dependent protein catabolic process, response to stress, axonogenesis, axon target recognition, adult walking behavior, cell death, cell proliferation, protein deubiquitination, sensory perception of pain, axon transport of mitochondrion, eating behavior, negative regulation of MAP kinase activity, muscle fiber development, neuromuscular process 209946_at VEGFC Angiogenesis, positive regulation of neuroblast proliferation, platelet degranulation, substratedependent cell migration, signal transduction, multicellular organismal development, blood coagulation, positive regulation of cell proliferation, organ morphogenesis, morphogenesis of embryonic epithelium, cell differentiation, platelet activation, regulation of vascular endothelial growth factor receptor signaling pathway, positive regulation of protein autophosphorylation, response to drug, positive regulation of blood vessel endothelial cell migration, negative regulation of blood pressure, vascular endothelial growth factor receptor signaling pathway, positive regulation of epithelial cell proliferation, positive regulation of protein secretion, positive chemotaxis, induction of positive chemotaxis, positive regulation of cell division, positive regulation of mast cell chemotaxis, positive regulation of lymphangiogenesis 232122_s_at VEPH1 - Table III . Common genes among the upregulated probe sets in MSCs compared with diffuse-type GC (U133Plus2.0) and the upregulated probe sets in diffuse-type GC compared with intestinal-type GC (U95Av2).
Ratio of MSCs Gene symbol
U95Av2 probe set ID U133Plus2.0 probe set ID (12) Figure 2 . Venn diagram of the extraction of common genes with upregulated probe sets in MSCs and upregulated probe sets in diffuse-type GC. Probe sets with an average signal intensity of >500 in MSCs and greater than a 2-fold change in MSCs compared with diffuse-type GC were selected from the U133Plus2.0 platform and were aligned with the U95Av2 platform. Furthermore, 94 probe sets were extracted that were upregulated in diffuse-type GC compared with intestinal-type GC on the U95Av2 platform. (20) (21) (22) . NOTCH1, which plays a well-known role in cancer development and EMT, was also upregulated in diffuse-type GC compared with MSCs. ID3 was downregulated in diffuse-type GC compared with MSCs. NANOG (Nanog homeobox), which is involved in maintaining the pluripotency of embryonic stem cells, was upregulated in diffuse-type GC compared with MSCs (Fig. 4C) . NANOG functions in conjunction with ten-eleven translocation (TET) family proteins, and TET1 enhances the efficacy of reprogramming (23) . TET1 was also upregulated in diffuse-type GC compared with MSCs.
These data indicating that embryonic stem cell-related genes may play a role in cancer cells in which EMT occurs, such as in diffuse-type GC rather than in MSCs, are very interesting; however, if particular EMT markers are overexpressed in MSCs, then these genes are unlikely to be useful for distinguishing diffuse-type GC from intestinal-type GC.
The mRNA ratio of CDH2 to CDH1 distinguished the mesenchymal from the epithelial phenotype. Using the microarray results, the mRNA ratios of CDH2 to CDH1 were compared in 12 MSC samples and 5 diffuse-type GC samples, and in 13 diffuse-type GC samples and 17 intestinal-type GC samples. The results and a diagram showing the phenotypic transition among the samples are shown in Fig. 5A . The mRNA ratio of CDH2/CDH1 was higher in MSCs than in diffuse-type GC. The mRNA ratio of CDH2/CDH1 was also higher in diffuse-type GC samples than in intestinal-type GC Figure 5 . Diagram of the cellular phenotype transition and the mRNA ratios of CDH2 to CDH1 and WNT5A to WNT4 in MSCs and GC. (A) A diagram of the mesenchymal to epithelial transition in MSCs, diffuse-type GC, and intestinal-type GC is shown (upper). The mRNA ratio of CDH2 to CDH1 in MSCs, diffuse-type GC, and intestinal-type GC was compared. (B) The mRNA ratio of WNT5A and WNT4 was also examined. The data are presented as the mean ± SE of the ratio to the average in the MSCs ( *** P<0.001 vs. MSCs; n=12 MSCs and n=5 diffuse-type GC) or the ratio to the average in diffuse-type GC ( # P<0.05 vs. diffuse-type GC; n=13 diffuse-type GC and n=17 intestinal-type GC).
samples. The combin ation of the CDH2 and CDH1 mRNA levels may distinguish the mesenchymal cell phenotype from the epithelial cell phenotype. WNT5A upregulation has been reported to be associated with EMT (7). The WNT5A/WNT4 ratio was higher in MSCs than in diffuse-type GC, whereas the WNT5A/WNT4 ratio was similar in the diffuse-and intestinaltype GCs (Fig. 5B) . Accordingly, the combination of WNT5A and WNT4 may only distinguish MSCs from GC.
We performed quantitative real-time RT-PCR to detect the expression of CDH1 and CDH2 in 6 MSC samples, 15 diffuse-type GC samples and 17 intestinal-type GC samples. In accordance with the above microarray results, CDH1 was upregulated and CDH2 was downregulated in GC compared with MSCs (Fig. 6) . The CDH2/CDH1 mRNA ratio was confirmed to be higher in MSCs than in both types of GC. Most importantly, the CDH2/CDH1 mRNA ratio was perfect at distinguishing the 15 diffuse-type GC samples from the 17 intestinal-type GC samples (Fig. 7) ; all of the 15 diffuse-type GC samples had ratios that were higher than the intestinal-type GC sample with the highest ratio (I-80).
VIM is one of the most validated EMT markers. Therefore, using quantitative real-time RT-PCR, we investigated the possibility that the combination of VIM and CDH1 could distinguish the mesenchymal phenotype from the epithelial phenotype (Fig. 8) . The VIM/CDH1 mRNA ratio was higher in MSCs than in both types of GC. However, the VIM/CDH1 ratio was much more varied among the 32 GC samples than the CDH2/CDH1 ratio. As mentioned above, there was a threshold CDH2/CDH1 ratio that distinguished the 15 diffuse-type GC samples from the 17 intestinal-type GC samples, whereas some intestinal-type GC samples (for example, I-11 and I-15) had a higher VIM/CDH1 ratio than certain diffuse-type GC samples.
Discussion
We previously compared the expression profiles of 18 intestinal-type GC and 12 diffuse-type GC samples with typical characteristics in terms of cell growth (clustered or scattered) and differentiation (well/moderate or poor), and selected genes based on their expression levels in the two types of cancer (7). The CDH2 to CDH1 mRNA ratio was significantly higher in diffuse-type GC than in intestinal-type GC. (B) The ratios in the two types of GC were compared. The data are presented as the mean ± SE of the ratio to the average in the diffuse-type GC samples ( *** A gene was selected using the Wilcoxon U test (P<0.05) from genes with more than a 2-fold change on average. By this procedure, a total of 892 genes were identified (704 genes specific to diffuse-type and 188 genes specific to intestinal-type). The two types of GC were completely separated by two-dimensional hierarchical clustering analysis of the 892 selected genes. In this paper, we reported that an EMT regulator, ZEB1/SIP1, is a target of the primary transcription factor GLI1 in the Hh signaling pathway in diffuse-type GC and that ZEB1/SIP1 further activates NOTCH2 and other EMT regulators [snail family zinc finger 2 (SNAI2) and twist family bHLH transcription factor 2 (TWIST2)]. SNAI2 upregulates CDH2 and WNT5A and downregulates CDH1. TWIST2 upregulates CDH2, ROR2, which is the WNT5A receptor, and other mesenchymal-related genes (PDGFRB, EDNRA, ROBO1 and MEF2C). Accordingly, we concluded that Hh signaling-mediated EMT specifically occurred in diffuse-type GC. This crosstalk between Hh signaling and EMT has been reported in esophageal squamous cell carcinoma (24) . However, we were unable to identify a single marker that distinguished the 12 diffuse-type GC samples from the 18 intestinal-type GC samples. Therefore, herein, we searched for such genes by comparing the expression profiles of diffuse-type GC and MSCs, which are typical mesenchymal cells. Among the 1461 probe sets that were significantly upregulated in MSCs, we selected 94 probes (77 genes) that were upregulated in diffuse-type GC compared with intestinal-type GC (Table III) .
The typical mesenchymal cell markers FN1, VIM and CDH2 were highly expressed in MSCs. Regarding EMT regulators, it is known that the Snail family transcription factor regulates EMT by repressing CDH1 gene transcription (25) . SNAI2 expression was higher in MSCs than in diffusetype GC. CDH1 gene regulation might be involved in EMT because it was shown that intracellular CDH1 is located at the membrane after treatment with siRNA targeting the EMT regulator ZEB2/SIP1 in esophageal cancer (24) . In terms of Wnt signaling, WNT5A was upregulated in MSCs compared with diffuse-type GC; however, its receptor ROR2 was more highly expressed in diffuse-type GC than in MSCs. Regarding Notch signaling, NOTCH1, 3 and 4 were highly expressed in the diffuse-type GC samples, whereas NOTCH2 was upregulated in MSCs. Because NOTCH is related to stem cell maintenance, this alteration in gene expression may reflect transitions or modifications in stem cell features (26) . In terms of other stem cell markers, a recent report suggested that Lgr5 + cells in mouse intestinal adenomas acquired the ability for cancerous growth as a stem cell (27) . Dclk1 (doublecortin-like kinase 1), which is a candidate marker for intestinal cancer stem cells, did not dramatically differ in expression between diffuse-type GC and MSCs (28) .
From these results, we selected FN1, VIM, CDH2, SNAI2, WNT5A and NOTCH2 as EMT-related genes that were upregulated in MSCs. However, all 6 of these genes were included in our previously-selected 704 genes that were upregulated in diffuse-type GC compared with intestinal-type GC. Therefore, we examined the power of the mRNA ratio of each of these 6 mesenchymal-related genes to a typical epithelial marker gene, CDH1. We determined that the mRNA ratio of CDH2 to CDH1 has great potential as a single indicator that distinguishes diffuse-type GC from intestinal-type GC. In the near future, the power of this simple indicator of EMT should be evaluated in a large cohort study of GC as well as other tumor types.
